DarioHealth (DRIO) Misses Q2 EPS by 14c

DarioHealth (NASDAQ: DRIO) reported Q2 EPS of ($0.99), $0.14 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $5.11 million.

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
• Alliance Global Partners Starts DarioHealth Corp. (DRIO) at Buy